“…aPDI employs light, air, and a photosensitizer (PS) to generate primarily singlet oxygen ( 1 O 2 ) as the biocidal agent, and represents a complementary strategy for the treatment of microbial infections [ 27 , 28 ]. Advantages of materials-based aPDI include (i) employing singlet oxygen as the biocidal agent (which, given its short lifetime and decay to harmless oxygen as an end product [ 29 ] can be considered environmentally benign); (ii) multiple routes to PS incorporation, including the attachment of the PS through electrostatic interactions [ 30 ], encapsulation within a polymeric matrix [ 30 , 31 , 32 , 33 , 34 , 35 , 36 ], or direct attachment via a covalent bond (prevents leaching into the environment) [ 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ]; (iii) the ability of the PS to potentially function in the absence of direct contact with the pathogen due to the diffusibility of singlet oxygen [ 40 , 45 ]; and (iv) of great importance with respect to nosocomial infections is that singlet oxygen or other photo-generated reactive oxygen species cause non-specific damage from which microbial resistance is unlikely to arise [ 27 , 46 , 47 ]. To this latter point, aPDI has been shown to possess broad-spectrum antibacterial [ 23 , 27 , 48 , 49 , 50 ], antiviral [ 31 , 51 , 52 , 53 ], antifungal [ 46 , 54 , 55 , 56 ], and antiparasitic [ 57 ,…”